News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
724,241 Results
Type
Article (73734)
Company Profile (195)
Press Release (650288)
Multimedia
Podcasts (154)
Webinars (29)
Section
Business (188441)
Career Advice (2820)
Deals (34305)
Drug Delivery (154)
Drug Development (84952)
Employer Resources (161)
FDA (17949)
Job Trends (15055)
News (336498)
Policy (35662)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (2942)
Academic (1)
Accelerated approval (45)
Adcomms (36)
Allergies (172)
Alliances (51523)
ALS (204)
Alzheimer's disease (1869)
Antibody-drug conjugate (ADC) (417)
Approvals (18190)
Artificial intelligence (669)
Autoimmune disease (236)
Automation (48)
Bankruptcy (358)
Best Places to Work (11408)
BIOSECURE Act (22)
Biosimilars (213)
Biotechnology (134)
Bladder cancer (181)
Brain cancer (72)
Breast cancer (713)
Cancer (5535)
Cardiovascular disease (481)
Career advice (2396)
Career pathing (45)
CAR-T (313)
CDC (63)
Celiac Disease (1)
Cell therapy (849)
Cervical cancer (43)
Clinical research (72473)
Collaboration (2024)
Company closure (5)
Compensation (846)
Complete response letters (90)
COVID-19 (2928)
CRISPR (103)
C-suite (1003)
Cystic fibrosis (157)
Data (7106)
Decentralized trials (3)
Denatured (47)
Depression (177)
Dermatology (59)
Diabetes (571)
Diagnostics (6696)
Digital health (51)
Diversity (13)
Diversity, equity & inclusion (41)
Drug discovery (341)
Drug pricing (238)
Drug shortages (37)
Duchenne muscular dystrophy (283)
Earnings (73828)
Editorial (71)
Employer branding (21)
Employer resources (147)
Events (100078)
Executive appointments (1059)
FDA (21490)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (29)
Funding (1664)
Gene editing (222)
Generative AI (68)
Gene therapy (705)
GLP-1 (1172)
Government (4937)
Grass and pollen (7)
Guidances (397)
Healthcare (18561)
HIV (78)
Huntington's disease (53)
IgA nephropathy (93)
Immunology and inflammation (302)
Immuno-oncology (89)
Indications (157)
Infectious disease (3259)
Inflammatory bowel disease (216)
Inflation Reduction Act (17)
Influenza (133)
Intellectual property (278)
Interviews (529)
IPO (15652)
IRA (61)
Job creations (3972)
Job search strategy (1966)
JPM (69)
Kidney cancer (19)
Labor market (80)
Layoffs (605)
Leadership (42)
Legal (8184)
Liver cancer (105)
Longevity (27)
Lung cancer (743)
Lymphoma (415)
Machine learning (55)
Management (55)
Manufacturing (957)
MASH (187)
Medical device (12961)
Medtech (13034)
Mergers & acquisitions (19772)
Metabolic disorders (1536)
mRNA (199)
Multiple sclerosis (180)
NASH (21)
Neurodegenerative disease (424)
Neuropsychiatric disorders (114)
Neuroscience (3359)
Neurotech (1)
NextGen: Class of 2026 (6495)
Non-profit (4784)
Now hiring (59)
Obesity (751)
Opinion (346)
Ovarian cancer (186)
Pain (244)
Pancreatic cancer (260)
Parkinson's disease (356)
Partnered (37)
Patents (564)
Patient recruitment (610)
Peanut (65)
People (57570)
Pharmaceutical (47)
Pharmacy benefit managers (36)
Phase 1 (22373)
Phase 2 (31551)
Phase 3 (23923)
Pipeline (7168)
Policy (354)
Postmarket research (3103)
Preclinical (9997)
Press Release (70)
Prostate cancer (285)
Psychedelics (59)
Radiopharmaceuticals (307)
Rare diseases (1083)
Real estate (6001)
Recruiting (71)
Regulatory (27789)
Reports (38)
Research institute (2730)
Resumes & cover letters (448)
Rett syndrome (33)
RNA editing (17)
RSV (86)
Schizophrenia (178)
Series A (280)
Series B (198)
Service/supplier (11)
Sickle cell disease (112)
Special edition (28)
Spinal muscular atrophy (184)
Sponsored (50)
Startups (3668)
State (2)
Stomach cancer (21)
Supply chain (124)
Tariffs (97)
The Weekly (105)
Vaccines (1158)
Venture capital (104)
Weight loss (511)
Women's health (109)
Worklife (21)
Date
Last 7 days (636)
Last 30 days (2488)
Last 365 days (29682)
2026 (7899)
2025 (30034)
2024 (34561)
2023 (39089)
2022 (50057)
2021 (54250)
2020 (52915)
2019 (46245)
2018 (35237)
2017 (33266)
2016 (32560)
2015 (37700)
2014 (30580)
2013 (27305)
2012 (28499)
2011 (29181)
2010 (28111)
Location
Africa (1010)
Alabama (99)
Alaska (6)
Arizona (276)
Arkansas (15)
Asia (45268)
Australia (7825)
California (11459)
Canada (3433)
China (1302)
Colorado (504)
Connecticut (531)
Delaware (338)
Europe (101836)
Florida (1759)
Georgia (369)
Hawaii (3)
Idaho (57)
Illinois (962)
India (85)
Indiana (528)
Iowa (21)
Japan (499)
Kansas (131)
Kentucky (45)
Louisiana (40)
Maine (81)
Maryland (1441)
Massachusetts (8212)
Michigan (333)
Minnesota (598)
Mississippi (5)
Missouri (138)
Montana (37)
Nebraska (29)
Nevada (132)
New Hampshire (81)
New Jersey (3213)
New Mexico (33)
New York (3181)
North Carolina (1523)
North Dakota (10)
Northern California (5538)
Ohio (357)
Oklahoma (25)
Oregon (41)
Pennsylvania (2301)
Puerto Rico (27)
Rhode Island (47)
South America (1296)
South Carolina (76)
South Dakota (1)
Southern California (4606)
Tennessee (185)
Texas (1883)
United States (41378)
Utah (348)
Vermont (1)
Virginia (296)
Washington D.C. (80)
Washington State (974)
West Virginia (3)
Wisconsin (119)
Wyoming (2)
724,241 Results for "strathcylde institute for drug research sidr".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Roche inaugurates new research home for the Institute of Human Biology, pioneering human model systems to accelerate drug discovery and development
March 23, 2026
·
4 min read
Press Releases
Panoramic Health and West Coast Kidney Institute Launch Concord Cardio-Renal Research Institute to Advance Clinical Trials in Cardio-Renal-Metabolic Disease
April 2, 2026
·
3 min read
Drug pricing
Pharma’s Reluctance To Serve Europe To Dodge MFN Drug Pricing Is Chilling
As Big Pharma companies consider foregoing European drug launches to avoid reducing drug prices in the U.S. in alignment with Trump’s Most Favored Nation policy, patients will suffer.
April 2, 2026
·
3 min read
·
Annalee Armstrong
Press Releases
Zealand Pharma Establishes U.S. Research Hub in Cambridge, Massachusetts to Expand Drug Discovery Capabilities and Accelerate Medicine Creation
March 24, 2026
·
7 min read
Opinion
Cut Down on Oncology Drug Waste With Better Forecasting
Billions of dollars’ worth of cancer drugs are discarded each year. Manufacturers must refund Medicare for some of this waste. A data-driven approach offers a practical path to greater efficiency.
February 24, 2026
·
5 min read
·
Vikas Mahajan
Press Releases
Fennec Pharmaceuticals Announces Clinical Research Collaboration with Tampa General Hospital Cancer Institute
March 4, 2026
·
15 min read
Press Releases
MACC Fund Commits $11.5 Million to Propel Pediatric Cancer Research at Versiti Blood Research Institute
March 4, 2026
·
4 min read
Press Releases
Feinstein Institutes’ scientists uncover ‘paradigm-shifting’ drug discovery strategy for sepsis, rheumatoid arthritis
February 18, 2026
·
4 min read
Approvals
Vanda Rebounds From Jet Lag Rejection With FDA Nod for Bipolar, Schizophrenia Drug
Bysanti is based on iloperidone, an active metabolite of a compound that forms the core of Fanapt, another drug by Vanda Pharmaceuticals.
February 23, 2026
·
2 min read
·
Tristan Manalac
Job Trends
Innovation Pressure Cooker: Tackling Drug Discovery’s Biggest Challenges
Drug discovery can be an uphill battle, especially lately given recent upheaval at the FDA and muted investment activity.
BioSpace
spoke to four industry executives about key issues facing those working in this space, starting with planning around uncertainty.
April 2, 2026
·
5 min read
·
Angela Gabriel
1 of 72,425
Next
